Core Viewpoint - The company has adjusted the exercise prices for its stock option incentive plans for 2023 and 2024, following the approval of the board of directors during the third meeting of the third board session held on November 18, 2025 [3][16][21]. Group 1: Board Meeting Details - The third meeting of the third board session was held on November 18, 2025, with all seven directors present, and the meeting was conducted in accordance with relevant laws and regulations [2][3]. - The board approved the proposal to adjust the exercise prices for the stock option incentive plans for 2023 and 2024 [3][16]. Group 2: Stock Option Incentive Plan Adjustments - The exercise price for the 2023 stock option incentive plan was adjusted from 22.14 yuan per share to 21.54 yuan per share, and the number of remaining stock options was updated to 24,159,353 shares after accounting for cancellations due to employee departures [12][21]. - The exercise price for the 2024 stock option incentive plan was adjusted from 25.92 yuan per share to 25.74 yuan per share [21]. - The adjustments were made in compliance with the company's stock option incentive plan regulations and were authorized by the shareholders' meeting, thus not requiring further shareholder approval [27][28]. Group 3: Legal and Compliance - The adjustments have been deemed compliant with relevant laws and regulations, including the Company Law and the Securities Law of the People's Republic of China [29]. - The company is required to continue fulfilling its information disclosure obligations and complete necessary registration procedures following these adjustments [29].
深圳市康冠科技股份有限公司第三届董事会第三次会议决议公告